Introduction 19
The diagnosis of pancreatic cancer (PC) is rarely made at an early stage and it has an 20 exceptionally low survival rate due to a late diagnosis and limited treatment options, making 21 it the seventh leading cause of cancer death worldwide with an almost equal number of new 22 cases diagnosed each year 1 . The burden of this cancer is increasing with an aging population, 23 and is particularly high in more developed countries. The incidence of pancreatic cancer 24 varies greatly across regions, which suggests a role of environmental, dietary or lifestyle 25 factors 2, 3 . Consistently identified risk factors for pancreatic cancer include tobacco smoking, 26 body fatness, conditions characterized by high insulin secretion, chronic pancreatitis, heavy 27 alcohol intake and family history of the disease [4] [5] [6] . Nonetheless, the aetiology of the cancer is 28 largely unknown and prevention strategies are limited. 29 Folate, naturally available in a wide variety of foods including fruits and vegetables, is a 30 water-soluble vitamin B that plays an important role in the synthesis and methylation of DNA 31 as a crucial cofactor in one-carbon metabolism together with other B vitamins such as 32 vitamin B2, vitamin B6 and vitamin B12 7 . Inadequate folate status may contribute to 33 carcinogenesis through aberrations in DNA methylation and uracil misincorporation, leading 34 to DNA instability 7-9 . 35 Previous epidemiological studies have shown inconsistent results for associations 36 between folate status and pancreatic cancer risk suggesting a weak inverse association with 37 dietary folate intake from natural sources, but not from supplements [10] [11] [12] [13] [14] . A recent meta-38 analysis supported this observation 15 whereas a large pooled analysis of 14 prospective cohort 39 studies found no association 16 . In the former meta-analysis, the overall estimates were from 40 both case-control and prospective cohort studies, and a significant heterogeneity was found 41 across those studies. In the latter pooled analyses, folate data might not be comparable across 42 studies and countries due to the use of various databases and analytical methods, thus 43 Accepted Article attenuating potential relationships with pancreatic cancer. A recent meta-analysis of 44 randomised trials of folic acid supplementation with an average duration of 5 years of 45 treatment found no significant effect on overall or site-specific cancer incidence including 46 pancreatic cancer 17 . The results from plasma measurements of folate intake in association 47 with pancreatic cancer were also inconclusive [18] [19] [20] . In a more recent nested case-control study 48 in the EPIC cohort, including 463 incident pancreatic cancer case, a weak U-shaped 49 association was observed between plasma folate and pancreatic cancer risk 18 . 50
The aim of this study was to investigate the association between dietary folate intake and 51 pancreatic cancer risk within the European Prospective Investigation into Cancer and 52 Nutrition (EPIC) study, benefitting from a large number of cases with an extended follow-up 53 time and standardised dietary folate intake data from a comprehensive EPIC Nutrient 54 DataBase (ENDB) where folate information was harmonized using common procedures and 55 guidelines, with support from the local national compilers in 10 countries participating in 56 EPIC 21 . 57 58
Subjects and Methods 59

Study population 60
The EPIC study is a multicentre prospective cohort study designed to investigate the 61 associations between diet and various lifestyle, environmental risk factors and the incidence 62 of different cancers and other chronic diseases. The full rationale and methods of the study 63 were reported elsewhere 22, 23 . Briefly, the EPIC cohort consists of 23 study centres in 10 64
European countries (Denmark, France, Greece, Germany, Italy, Netherlands, Norway, Spain, 65
Sweden, and the UK), with over 521,330 participants. EPIC participants were mostly 66 recruited from the general population residing within defined geographical areas between 67 Accepted Article 7 1992 and 2000, with some exceptions: women members of a health insurance for school 68 employees (France); women attending breast cancer screening (Utrecht, the Netherlands,  69 Florence, and Italy); blood donors (centres in Italy and Spain) and a cohort with a large 70 proportion (approximately 50%) of vegetarians ('health conscious' cohort in Oxford, UK). 71
The participants completed dietary and lifestyle questionnaires and had their anthropometric 72 measurements recorded by trained health professionals (self-reported in France, Norway and 73 Oxford). All participants gave their written informed consent, and the study was approved by 74 the local ethics committee in the participating countries and the Ethics Committee of the 75 Internal Agency for Research on Cancer, Lyon, France. 76 Our study is based on data from 477,206 participants (142,228 men and 334,978 77 women) after a priori exclusion of individuals with prevalent cancer at recruitment, missing 78 diagnosis or censoring date, missing dietary or lifestyle information, and implausible extreme 79 values in the top and bottom one percent of the distribution of the ratio of reported total 80 energy intake to estimated energy requirement (estimated from age, sex, and body weight and 81 height). 82
83
Diet and lifestyle data 84
Diet including folate and other B vitamins over the previous 12 months was measured by 85 country/centre-specific validated dietary assessment methods, mostly food frequency 86 questionnaire designed to capture local dietary habits and to allow high compliance. The 87 relative validity and reproducibility of the questionnaires has previously been published 24 . 88
The questionnaire, validated within each count ry, was self-administered in all centres, except 89 in Greece, two Italian centres, and Spain, where it was administered by interviewers. 90
Dietary folate intake was estimated using the updated EPIC Nutrient DataBase (ENDB) 21 . 91
The ENDB project was initiated and nutrient databases were harmonized using common 92
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procedures and guidelines, with support from the local national compilers in 10 countries in 93 EPIC 25 . The ENDB was first completed for 26 priority components to provide a standardised 94 reference instrument for calibrating the EPIC dietary measurements at the nutrient level 26 . 95
This work has been extended to cover other nutrients including folate and other B vitamins 21 96 Although the ENDB values were obtained from country-specific food composition tables, 97 they were standardized as much as possible across the EPIC countries by matching of EPIC 98 foods to the national databases according to the recommendation given in a recent review 21 . 99 In particular, a microbiological assay was chosen as the reference analytical method for folate 100 values in the ENDB. Folate values of unavailable foods were derived by recipe calculation or 101 borrowed from similar foods 21 . During the ENDB compilation for folate, to address the issue 102 of voluntary fortification of breakfast cereals particularly in the UK and France where cereal 103 consumption was substantially higher, aggregation was re-done taking into account the brand 104 names and folic acid fortification levels of cereals 21 . 105 In the Scandinavian countries and in the Netherlands, folate fortification was not allowed 106 at the time of data collection. In other EPIC countries, breakfast cereal consumption was very 107 low and the information on folic acid-fortified foods was not always available 21 . It was 108 therefore, decided not to adopt the dietary folate equivalent (DFE) conversion which 109 considers lower bioavailability of naturally occurring folate compared to synthetic folic acid. 110
Information on dietary intakes of other nutrients including other B vitamins was also 111 estimated using the ENDB. 112
Self-reported data on lifestyle factors, including total physical activity, educational level, 113 smoking history, diabetes status and ever use of vitamin or mineral supplements considered 114 in the analysis were collected at baseline through standardised questionnaires and clinical 115 examinations, and have been described elsewhere 23, [27] [28] [29] [30] . 116 117
Endpoints 118 Incident pancreatic cancer cases were identified through population cancer registries 119 (Denmark, Italy, Netherlands, Norway, Spain, Sweden, and the UK) or by active follow-up 120 (France, Germany, Naples, and Greece). The active follow-up procedure used a combination 121 of different strategies, including health insurance records, cancer and pathology registries, 122 and contacts with participants and their next of kin 23 . Participants were followed up from 123 study entry until cancer diagnosis (except non-melanoma skin cancer), death, emigration or 124 until the end of the follow-up period, whichever occurred first. Forty-five cases were 125 censored because the tumours were neuroendocrine (n = 42), benign (n = 1), carcinoma in 126 situ (n = 1), or with uncertain primary origin (n = 1). After a mean follow-up of 127 approximately 11 years, 865 first incident pancreatic cancers were available for analysis and 128
were classified corresponding to the International Classification of Diseases 10th revision as 129 C25 (C25.0-C25.3 and C25.7-C25.9). 130 131
Statistical analysis 132
Multivariable Cox proportional hazard models were fitted to estimate the hazard ratios (HRs) 133 and 95% confidence intervals (CIs). Disease models were fitted with intake of folate and 134 other B vitamins as continuous variables and categorisation of the variables in quartiles based 135 on the distribution of the whole study population. Dietary folate intake and other nutrients 136 were energy adjusted using the residual method 31 . To preserve the geographical specificity in 137 the dietary assessment in EPIC, centre-specific residuals for total dietary folate were 138 computed. Centre-specific mean values were then added to residuals to recuperate the 139 original scale and ease interpretability. 140
The following potential confounders were considered based on the literature review: total 141 energy intake (kcal/d), BMI (kg/m 2 ), physical activity (<moderately inactive/≥moderately 142
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This article is protected by copyright. All rights reserved. active), smoking status (never/former/current), education (<secondary school/ ≥secondary 143 school), ever use of vitamin or mineral supplements (no/yes), history of diabetes (no/yes) and 144 intake of other dietary factors (g/day) including dietary fibre, carbohydrate, and alcohol. In 145 the multivariable models, the variables that changed the unadjusted risk estimate by at least 146 ~10% were considered as confounders and adjusted for. These include smoking status, BMI, 147 educational level, history of diabetes, supplement use and dietary fibre intake. Energy intake 148 was further included in the model for complete energy adjustment 31 even though it did not 149 alter the unadjusted risk substantially. 150
Quartiles of dietary folate intake were determined on the basis of the whole cohort, with 151 the lowest quartile as the reference. Disease models were stratified by age at recruitment, sex, 152
and study centre (Model 1) and adjusted for smoking status, total energy intake and BMI, 153 education, diabetes status, supplement use and dietary fibre intake (Model 2). A test for trend 154 was made by modelling a score variable using quartile-specific medians as a continuous 155 variable. In addition, the association between dietary folate and the risk of pancreatic cancer 156 was examined using four-knot restricted cubic splines 32 with the median of the fifth decile of 157 folate intake as the reference category. 158
Alcohol intake was not considered as a covariate in the models as it did not change the 159 unadjusted risk estimates. However, alcohol has a role as a folate antagonist and has been 160 shown to have suppressive effects on methyl group metabolism 33 , and we investigated the 161 association according to tertiles of alcohol consumption. Likewise, we further explored the 162 association between dietary folate intake and pancreatic cancer risk stratified by smoking 163 status as smoking has been the most consistently known risk factor for pancreatic cancer and 164 current smoking status was related to lower dietary folate intake 34 . Models with main effects 165 and cross-product terms were fitted to test for interactions. 166
The effect of very high (≥500 µg/d) or very low folate intake ( <150 µg/d) in relation to 167 pancreatic cancer risk was additionally explored, with the reference category set at 200-300 168 µg/d, which was observed to be the average intake range in a previous EPIC study comparing 169 standardised dietary folate intake across ten participating countries 34 . 170
A model including the combined effects of folate tertiles and three smoking categories in 171 relation to overall pancreatic cancer risk was developed and the joint effects was presented in 172 comparison with never smokers in the highest folate tertile as a reference. Table 1 shows 186 baseline characteristics of the participants according to quartiles of energy-adjusted dietary 187 folate intake. Participants in the highest category of folate intake tended to be more educated, 188
were less likely to report being a current smoker and more likely to be physically active or 189
This article is protected by copyright. All rights reserved. dietary supplement users; and consumed more dietary fibre, fruit and vegetables compared 190 with those with lower dietary folate intake. 191
When we investigated energy-adjusted folate intake as a continuous variable in 192 association with pancreatic cancer in the fully adjusted model, we found an HR of 1.03 (95% 193 CI: 0.83, 1.28; P=0.78) for an increment of 100 μg/day of dietary folate intake 194 (approximately 1 SD). When folate intake was categorised into quartiles, higher dietary folate 195 intake showed a borderline statistically significant association with lower risk of pancreatic 196 cancer (Model 1, Table 2 ). The trend became attenuated and did not reach statistical 197 significance in Model 2 after multivariable adjustment ( Table 2) : the multivariable HR of 198 pancreatic cancer for those in the highest category of folate intake (≥353 μg/day) compared 199 with the lowest category of intake (<241 μg/day) was 0.81 (95% CI: 0.51, 1.31; P trend = 0.38). 200
Among the variables included in the Model 2, smoking and dietary fibre intake changed the 201 unadjusted risk estimate most. Our non-linear multivariable modelling of the association 202 using cubic spline confirmed no significant trend (Figure 1) . Further analysis using 203 continuous folate intake with a quadratic term provided no evidence of a non-linear 204 association between folate intake and pancreatic cancer risk (P quadratic term =0.56). 205
When we investigated the association according to alcohol consumption, there was no 206 evidence of a differential relationship according to levels of alcohol intake (P interaction = 0.82, 207 Table 2 ). In a subgroup analysis by smoking status we observed an increased risk of 208 pancreatic cancer with increasing folate intake in current smokers while no significant 209 associations were observed in never and former smokers: the multivariable HR of pancreatic 210 cancer among current smokers and those who had folate intake between 292 and 352 μg/day 211 and those who consumed more than 353 μg/day compared with the lowest category were 4.52 212 (95% CI: 1.59, 12.88) and 4.42 (95% CI: 1.05, 18.62), respectively (P trend = 0.01, Table 2 ). 213
The results did not differ when alcohol was additionally adjusted for. Nonetheless, an 214
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The characteristics of the participants in this study varied according to their smoking 217 status. Current smokers were younger, more likely to be men, to have a lower educational 218 level, and less likely to be diabetic at baseline, tended to have lower folate, fibre, fruit and 219 vegetable intakes and consumed more alcohol compared to never smokers (data not shown). 220
Further alcohol adjustment in the main models did not change the risk estimates stratified by 221 smoking status. When we considered smoking intensity in current smokers by adjusting for 222 number of cigarettes smoked per day, the results showed a greater than five-fold increased 223 risk in those who had a folate intake of more than 292 μg/d (data not shown). 224
The observed increased risk of pancreatic cancer with higher folate intake in current 225 smokers was further explored by choosing one single reference category (≥330 μg/day of 226 dietary folate intake and never smoker) and combined effects were determined for tertiles of 227 folate intakes in combination with categories of smoking status in relation to pancreatic 228 cancer risk (Figure 2) . A more than 50% increase in pancreatic cancer risk was observed in 229 current smokers regardless of the levels of folate intake, although a significantly higher risk 230 was observed among those who consumed more than 258 μg/day of folate. 231
We also explored the effect of very high (≥500 µg/d) or very low folate intake (<150 232 µg/d) in relation to pancreatic cancer risk, and we did not observe any significant associations 233 in the multivariable adjusted model, possibly due to limited statistical power ( Table 3) . 234
When we conducted a sensitivity analysis among those who reported not to take any 235 dietary supplements (n=237,113), the results did not change substantially (HR of 0.90, 95% 236 CI: 0.60, 1.35; P=0.61 for an increment of 100 μg/day folate, HR for the highest quartile vs. 237 lowest: 0.61, 95% CI: 0.26, 1.44; P trend = 0.28). Similarly, the results hardly changed when 238 Accepted Article we excluded the pancreatic cancer cases incident within the first 2 years of follow-up (n=90 239 cases) and repeated the analyses (HR of 1.03, 95% CI: 0.82, 1.29; P=0.79 for an increment of 240 100 μg/day, HR for the highest quartile vs. lowest: 0.79, 95% CI: 0.48, 1.30; P trend = 0.32). A 241 sensitivity analysis restricting the analyses to the microscopically confirmed cases did not 242 alter the results. 243 244
Discussion
245
To our knowledge, this study that analysed 865 incident pancreatic cancer cases, is the 246 largest single study so far that investigated the association between dietary folate intake and 247 pancreatic cancer risk. Within a unique international setting of European populations with 248 diverse dietary habits and lifestyle characteristics, we found no overall association between 249 dietary folate intake and pancreatic cancer risk. 250
There have been relatively few published single prospective studies that examined the 251 association between dietary folate intake and pancreatic cancer risk (summarised in Table 4 ). 252
Previous studies showed inconsistent results: they were heterogeneous by sex, ranges of 253 dietary folate intake, supplement use, and confounding factors that were adjusted for in the 254 analyses ( Table 4 ). Including studies conducted in the US, where dietary supplement use is 255 widespread, there is little evidence that folic acid intake from supplements was associated 256 with pancreatic cancer risk, while dietary folate intake was shown to be possibly related with 257 lower risks in some, but not in all studies ( Table 4 ). Only one study from the US was able to 258 distinguish the difference in dietary folate intake from natural sources and from folic acid 259 fortification 12 . In this study, no association was found in men, while women in the highest 260 quartile of food folate intake showed a significant 53% reduction in pancreatic cancer risk 261
Accepted Article compared with those in the lowest quartile. No significant association was found between 262 supplemental folic acid use and pancreatic cancer risk 12 . 263 Three meta-analyses 15, 35, 36 have reported a generally decreased risk of pancreatic cancer 264 with increasing dietary folate intake based on the above mentioned cohort studies together 265 with case-control studies, with significant heterogeneity reported in the two 15, 36 . The 2012 266
Continuous Update Project (CUP) Report of the WCRF/AICR Export Report weakened the 267 conclusions from the 2007 Expert Report, after reviewing evidence from five prospective 268 cohort studies, concluding the evidence is too inconsistent to allow a firm conclusion to be 269 drawn 4 
. 270
A large pooled analysis of 14 prospective cohort studies showed that dietary folate intake 271 was not associated with overall risk of pancreatic cancer 16 . The summary relative risk for the 272 highest vs. the lowest quintile of folate intake was 1.06 (95% CI: 0.90-1.25, P heterogeneity =0.15) 273 16 . In the pooled analysis, folate data may be heterogeneous across studies and countries as 274 studies rely on each country's own food-composition data which tend to vary in terms of 275 availability and quality of folate values 37, 38 . This may have an influence in a potential 276 relationship. It has been pointed out that there is a lack of clarity and consistency in the 277 terminology and definitions used for folate information in the food composition tables 278 available in Europe due to the specific complexity of folate 39 . A recent critical evaluation of 279 folate data in 18 European and international databases concluded that a lack of comparability 280 still exists between countries 40 . To overcome this, our study results came from the 281 standardised food and nutrient data linked to the ENDB with recently updated folate 282
information. 283
Despite the recent increasing use of dietary supplements in many European countries, the 284 use of folic acid supplement was not a common practice when our baseline data were 285 collected 10, 41 . Indeed, folic acid-containing supplements were not among the most frequently 286
Accepted Article consumed types of supplements in the EPIC study according to the 24 hour-recall data that 287 were collected in a sub group of participants with more detailed information on supplement 288 use at the baseline 41 . In addition, folic acid fortification was not widespread at the time of the 289 baseline information collection in Europe 21 . Thus, we had the unique opportunity to assess 290 the association between baseline dietary folate intake and pancreatic cancer risk, with 291 minimum influence of folic acid fortification or supplementation in the EPIC study. This was 292 confirmed when we conducted a sensitivity analysis excluding ever users of vitamin and 293 mineral supplements and the results did not materially change. 294
In our study, we observed a greater than four-fold elevated risk in current smokers with 295 higher dietary folate intake while in never or former smokers the risks were lower and non-296 significant. Current smokers have a higher chance to harbour precursor lesions in the 297 pancreas, and increased availability of folate may promote proliferation of already existing 298 neoplastic cells 42, 43 . We investigated this further by excluding cases diagnosed within the 299 first two or three years of follow-up which did not alter the results. Previous studies have 300
shown inconsistent results with regards to smoking status. While a previous EPIC nested 301 case-control study that investigated plasma folate levels in relation to pancreatic cancer risk 302 did not show any heterogeneity across smoking status 18 , an inverse association with 303 pancreatic cancer risk was reported with both dietary folate intake 14 and serum folate levels 19 304 in a cohort of Finnish male smokers. In the large pooled analysis of cohort studies, there was 305 no effect modification by smoking status with dietary folate intake 16 . Although increased 306 pancreatic cancer risk observed in current smokers in our study, especially in participants 307 with dietary folate intake higher than 292 μg/day may be worth exploring further in future 308 studies, few cases included, no statistically significant interaction found, potential role of 309 residual confounding or chance require cautious interpretation of the results. 310
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The current study has limitations. We did not have information on occurrence of 311 pancreatitis in the study population which might have affected pancreatic cancer risk. Neither 312 did we have repeated information during the follow-up period to assess any potential changes 313 in dietary intakes over time. In addition, we relied on self-reported dietary folate intake. 314 However, the overall results did not substantially differ from the previous EPIC study that 315 investigated plasma folate level in association with pancreatic cancer risk 18 . In our study, the 316 range of dietary folate intake was quite narrow, as shown previously in the results using the 317 24-hour dietary recall methods 34 , with too few participants with either very low or very high 318 intakes. It was therefore not possible to explore the effect of extreme folate intake on 319 pancreatic cancer risk with sufficient statistical power. We used self-reported smoking status 320 which might be inaccurate. However, a recent EPIC study of plasma cotinine level and 321 pancreatic cancer risk compared the cotinine level against self-reported smoking status and 322 concluded that self-reported smoking status was sufficient to establish a causal relationship 323 and did not underestimate its relationship with pancreatic cancer risk 44 . 324 In conclusion, using standardised data from this large, multi-centre prospective study, we 325 found no association between dietary folate intake and pancreatic cancer risk. 326
Data sharing statement: For information on how to submit an application for gaining access to EPIC data and/or biospecimens, please follow the instructions at http://epic.iarc.fr/access/index.php. 
